RB1 and neoplasm: Despite the apparent paradox of one tumor suppressor degrading another, the prior data describing the synthetic lethality of Vhl and Rb1 loss [49], and pRb’s role in modulating hypoxic cell death [74], led us to validate pRb as our top hit.